+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Diversity in Parkinson’s Disease Research Grant

American Parkinson Disease Association

Letter of Intent open: Nov 28, 2025

Letter of Intent due: Jan 30, 2026

Invitation for full application: March 20, 2026

Full Application due: June 5, 2026

Award details

One year grant up to a maximum of $75,000 will be awarded to research scientists (MD, MD/PhD, or PhD).

The applicants will receive notification of the decision in October 2026. The APDA grant year runs from January 1 to December 31, 2027.

Goal

APDA Diversity in PD Research Grant is a one-year grant to study the health inequities and/or differences among under-studied PD communities, across the spectrum of ethnicity, ancestry, geography, socioeconomic conditions, and gender. Current research has established the following:

Diagnosis of PD among some under-studied communities is delayed.
Some under-studied communities are less likely to receive quality PD care.
Clinical trial enrollment among certain under-studied communities does not match their representation in the population.
Differences in clinical features, response to treatment, co-morbidities, prevalence, natural history, genetics and biomarkers among various under-studied PD populations have not been fully explored.

Projects should address one of these four issues. Projects can be designed to detect inequities or differences, understand the reasons for the inequities or differences, or test an intervention to improve disparities.

AI Based Application Success Predictor

1️⃣ Clear, Central Parkinson’s Disease Focus

Projects must directly contribute to:

Disease mechanisms relevant to PD

Motor & non-motor symptoms (sleep, cognition, mood, autonomic issues)

Movement-disorder therapeutics and outcomes

Biomarker development (imaging, biofluids, wearable tech)

Access to PD care or support

🛑 Vague neuroscience unrelated to PD = low score.

2️⃣ Strong Translational or Clinical Relevance

APDA wants impactful advances for people living with PD:

Improved diagnosis, earlier detection

Better symptom management / reduced disability

Novel therapeutics targeting disease modification

Real-world functional gains, caregiver support, health equity

“How will this help PD patients in the near-future?” is the silent killer question.

3️⃣ Feasible Pilot-Scale Design (1–2 Strong Aims)

Common features of funded studies:

12–24 month timeline

Small, focused scope

Rapid generation of publishable data

Clear milestones

Overly ambitious = reviewer skepticism.

4️⃣ Early-Career Momentum + Strong Mentorship (if applicable)

For fellowships / junior awards:

Well-aligned PD mentor with track record

Protected time for research

Institutional commitment letter

Evidence of potential: early pubs, posters, movement disorders training

APDA likes backing rising stars.

5️⃣ Solid Rationale + Preliminary Data (If Beyond Exploratory)

Pilot data showing feasibility

Biological / mechanistic justification for the therapeutic model

Early effect signal or technical capability evidence

No “fishing expeditions” — hypothesis-driven is best.

6️⃣ Real Plan for Follow-on Funding

APDA is a launch pad organization.

Strong proposals explicitly state:

How pilot data → NIH (R21/R01/K award), DoD, MJF Foundation, etc.

Competitive positioning vs. existing PD trials or innovations

Future trajectory = strategic value.

7️⃣ Patient-Centered Outcomes + DEI/Access Considerations

Increasing reviewer emphasis on:

Underserved populations (rural, minority, low-income)

Caregiver burden reduction

Telehealth, community-based care programs

Digital monitoring for home-based PD management

Broad real-world benefit = stronger mission alignment.

🚫 Common Reasons Proposals Fail

Pitfall	Problem
PD mentioned but not central to aims	Lacks mission alignment
Too large / complicated for budget	Low feasibility
Weak mentorship (junior applicants)	Execution risk
No pathway to clinical impact	Reviewer “so what?” reaction
Poor statistical design / vague methods	Rigor concerns
No clear next funding step	Limited ROI

🎯 APDA Proposal Success Checklist

✔ Central PD mechanism or patient-impact focus
✔ 1–2 tight aims, feasible in 1–2 years
✔ Innovation that matters to patient care
✔ Preliminary data or compelling logic
✔ Strong mentorship & protected time (if early-career)
✔ Plan for publications + future grants
✔ Clear, polished writing + appropriate statistics
✔ Meaningful patient outcomes & health equity consideration

Specialties

Neurosciences

Eligibility Requirements

U.S.-based research scientists in the field of Parkinson’s research can apply.

Sponsor Details

Sponsor Institute/Organizations: American Parkinson Disease Association

Sponsor Type: Corporate/Non-Profit

Address: PO Box 61420 Staten Island, NY 10306

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity